Innovation Pharmaceuticals Inc (IPIX)

[KMBJN]

Agree that inhaled brilacidin would be very interesting. Heck any trial they can run with brilacidin would be interesting. We need to get going with some more trials, if we have the funds or can secure grant money or partners to fund.

Leronlimab blocks HIV entering immune cells by blocking chemokine receptor CCR5 on CD4 T-cells. It has no direct antiviral activity against SARS2, although it does help restore the immune system so it can do its job to remove SARS2 (by keeping TRegs away, and also somehow by restoring lowered CD4 and CD8 T-cell counts). It is an immunomodulator primarily (blocking CCR5 receptor on immune cells). It is extremely promising in many indications (HIV, cancer, COVID-19, autoimmune disease, inflammatory diseases in general), and I have made it my largest biotech holding.

With more lab results expected to come out for brilacidin soon, it may be time to top-up IPIX for a bump with results.